Equities

Abingdon Health PLC

ABDX:LSE

Abingdon Health PLC

Health CareMedical Equipment and Services
  • Price (GBX)10.75
  • Today's Change-0.25 / -2.27%
  • Shares traded494.75k
  • 1 Year change30.30%
  • Beta-0.4532
Data delayed at least 20 minutes, as of May 17 2024 16:10 BST.
More ▼

Profile data is unavailable for this security.

About the company

Abingdon Health plc provides lateral flow contract development and manufacturing (CDMO services) and related contract services to an international customer base. It offers its services to an international customer base across industry sectors, which include clinical, self-testing, animal health, plant health, and environmental testing. Its segments include Product sales, Contract manufacturing, Contract development, and Regulatory. Its regulatory services include technical file build, regulatory filing support, implementation of quality management systems and quality assurance. The Company’s CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an ecommerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing.

  • Revenue in GBP (TTM)5.34m
  • Net income in GBP-2.24m
  • Incorporated2008
  • Employees82.00
  • Location
    Abingdon Health PLCYork Biotech Campus, Sand HuttonYORK YO41 1LZUnited KingdomGBR
  • Phone+44 19 0440 6050Fax+44 19 0446 2122
  • Websitehttps://www.abingdonhealth.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Bivictrix Therapeutics PLC0.00-2.33m9.49m10.009.49m10.00
Cambridge Nutritional Sciences PLC9.05m-3.21m9.52m91.009.52m91.00
ImmuPharma PLC69.96k-2.99m10.02m13.0010.02m13.00
Kanabo Group PLC895.00k-7.99m10.75m20.0010.75m20.00
Proteome Sciences plc5.03m-2.44m11.51m35.0011.51m35.00
Chill Brands Group PLC146.62k-3.64m12.40m2.0012.40m2.00
Provexis plc598.08k-496.59k13.58m2.0013.58m2.00
Abingdon Health PLC5.34m-2.24m13.62m82.0013.62m82.00
Shield Therapeutics PLC13.09m-33.29m13.69m73.0013.69m73.00
Synairgen plc0.00-9.99m14.10m30.0014.10m30.00
Destiny Pharma PLC0.00-5.66m15.01m19.0015.01m19.00
Genincode PLC1.72m-6.73m15.48m28.0015.48m28.00
LungLife AI Inc36.22k-4.26m15.75m15.0015.75m15.00
OptiBiotix Health PLC689.10k-13.17m17.75m3.0017.75m3.00
Oncimmune Holdings PLC1.15m-6.15m18.16m56.0018.16m56.00
Incanthera PLC0.00-1.48m18.86m8.0018.86m8.00
Data as of May 17 2024. Currency figures normalised to Abingdon Health PLC's reporting currency: UK Pound GBX

Institutional shareholders

10.16%Per cent of shares held by top holders
HolderShares% Held
Hargreaves Lansdown Asset Management Ltd.as of 08 Sep 202310.43m8.57%
Unicorn Asset Management Ltd.as of 30 Apr 20241.93m1.58%
Data from 02 Apr 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.